Yu Sunakawa

41PUBLICATIONS
189CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 18, 2026
A prospective study evaluating the impact of waiting time on blood testing and clinical workflows in cancer patients.

|Aug 27, 2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Jun 12, 2026
Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations.

|May 23, 2026
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens.

|May 20, 2026
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.

Pageof 7

Frequent Collaborators

13 joint publications

Takayuki Yoshino

10 joint publications

Hideaki Bando

10 joint publications

Yoshiaki Nakamura

9 joint publications

Hisateru Yasui